Trueblood Wealth Management’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$741K Sell
5,952
-1,364
-19% -$237K 0.26% 122
2026
Q1
$1.45M Sell
7,316
-249
-3% -$58K 0.57% 53
2025
Q4
$2.03M Sell
7,565
-1,102
-13% -$280K 0.79% 25
2025
Q3
$2.14M Sell
8,667
-525
-6% -$137K 0.83% 19
2025
Q2
$2.75M Sell
9,192
-87
-0.9% -$26.5K 1.15% 11
2025
Q1
$2.9M Sell
9,279
-778
-8% -$275K 1.34% 8
2024
Q4
$3.54M Buy
10,057
+33
+0.3% +$11.9K 1.74% 4
2024
Q3
$3.54M Sell
10,024
-58
-0.6% -$19.1K 1.78% 4
2024
Q2
$3.06M Sell
10,082
-332
-3% -$102K 1.73% 4
2024
Q1
$3.61M Buy
10,414
+329
+3% +$120K 2.07% 4
2023
Q4
$3.54M Buy
+10,085
New +$3.25M 2.22% 4

Other funds holding ACN

Trueblood Wealth Management's ACN Position: Q2 2026 in Review

Trueblood Wealth Management reduced its Accenture (ACN) stake by 19% in Q2 2026, selling an estimated $237K and leaving 5,952 shares worth $741K. The position accounts for 0.26% of the portfolio, ranked #122.

Trueblood Wealth Management first reported a position in ACN in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.61M in Q1 2024. 740 funds tracked by Wall St. Rank hold ACN as of Q2 2026.

  • Trueblood Wealth Management held 5,952 shares of Accenture worth $741K as of Q2 2026.
  • Trueblood Wealth Management sold 1,364 Accenture shares in Q2 2026, an estimated $237K.
  • Accenture made up 0.26% of Trueblood Wealth Management's portfolio in Q2 2026, its #122 holding.
  • Trueblood Wealth Management first reported a position in Accenture in Q4 2023 and has held it in 11 quarters since.
  • Trueblood Wealth Management's Accenture position peaked at $3.61M in Q1 2024.
  • 740 funds tracked by Wall St. Rank held Accenture as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.